[1]黄定蒙.不同等级医院晚期胃肠恶性肿瘤治疗效果及生活质量比较[J].医学信息,2023,36(02):127-129.[doi:10.3969/j.issn.1006-1959.2023.02.026]
　HUANG Ding-meng.Comparison of Treatment Effect and Quality of Life of Advanced Gastrointestinal Malignant Tumors in Different Grade Hospitals[J].Journal of Medical Information,2023,36(02):127-129.[doi:10.3969/j.issn.1006-1959.2023.02.026]
点击复制

不同等级医院晚期胃肠恶性肿瘤治疗效果及生活质量比较()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年02期
页码:
127-129
栏目:
临床研究
出版日期:
2023-01-15

文章信息/Info

Title:
Comparison of Treatment Effect and Quality of Life of Advanced Gastrointestinal Malignant Tumors in Different Grade Hospitals
文章编号:
1006-1959（2023）02-0127-03
作者:
黄定蒙
（苍南县第三人民医院/温州医科大学附属二院江南分院普外科，浙江 温州 325804）
Author(s):
HUANG Ding-meng
(Department of General Surgery,the Third People’s Hospital of Cangnan County/Jiangnan Branch of the Second Affiliated Hospital of Wenzhou Medical University,Wenzhou 325804,Zhejiang,China)
关键词:
不同等级医院; 晚期; 胃肠恶性肿瘤; 生活质量
Keywords:
Different grade hospital; Advanced stage; Gastrointestinal malignant tumor; Quality of life
分类号:
R735
DOI:
10.3969/j.issn.1006-1959.2023.02.026
文献标志码:
A
摘要:
目的 研究不同等级医院治疗对晚期胃肠恶性肿瘤临床疗效及生活质量的影响。方法 回顾分析2017年6月-2018年12月在苍南县第三人民医院就诊的150例晚期胃肠恶性肿瘤患者临床资料，其中既往在三级医院就诊患者定义为观察组（n=77），在基层医院就诊患者定义为对照组（n=73）。比较两组患者治疗总有效率、生存期、生活质量水平、不良反应发生率以及治疗成本。结果 观察组治疗总有效率为79.22%，与对照组的75.34%比较，差异无统计学意义（P＞0.05）；观察组结肠癌、胃癌患者生存时间、总生存时间、生活质量各维度评分、疲乏、恶心、疼痛、失眠、食欲丧失、腹泻各不良反应发生率与对照组比较，差异无统计学意义（P＞0.05）；观察组治疗成本高于对照组（P＜0.05）。结论 不同等级医院晚期胃肠恶性肿瘤疗效、生存期、生活质量以及不良反应发生情况相似，但是高等级医院治疗会一定程度增加医疗成本。
Abstract:
Objective To study the effect of different levels of hospital treatment on the clinical efficacy and quality of life of advanced gastrointestinal malignant tumors.Methods The clinical data of 150 patients with advanced gastrointestinal malignant tumors who were treated in the Third People’s Hospital of Cangnan County from June 2017 to December 2018 were retrospectively analyzed. Among them, patients who were previously treated in tertiary hospitals were defined as observation group (n=77), and patients who were treated in primary hospitals were defined as control group (n=73). The total effective rate, survival time, quality of life, incidence of adverse reactions and treatment cost were compared between the two groups.Results The total effective rate of treatment in the observation group was 79.22%, which was compared with 75.34% in the control group, the difference was not statistically significant (P>0.05). There was no significant difference in survival time, total survival time, the scores of quality of life ,the incidence of adverse reactions such as fatigue, nausea, pain, insomnia, loss of appetite and diarrhea between the observation group and the control group (P>0.05). The treatment cost of the observation group was higher than that of the control group (P<0.05).Conclusion The curative effect, survival time, quality of life and adverse reactions of advanced gastrointestinal malignant tumors in different grade hospitals are similar, but the treatment in high grade hospitals will increase the medical cost to a certain extent.

参考文献/References:

[1]Chen W,Zheng R,Zeng H,et al.The incidence and mortality of major cancers in China, 2012[J].Chin J Cancer,2016,35(1):73.[2]Akasaka T,Hokimoto S,Sueta D,et al.Clinical outcomes of percutaneous coronary intervention for acute coronary syndrome between hospitals with and without on site cardiac surgery backup[J].J Cardiol,2017,69(1):103-109.[3]张丽静.阿帕替尼联合SOX方案化疗治疗晚期胃癌合并顽固性癌性腹水患者的疗效[J].包头医学,2020,44(3):14-16.[4]杨永光,李立,徐志伟,等.分级诊疗制度下河南省不同等级医院慢性病患者住院费用比较[J].医学与社会,2018,31(8):22-24.[5]Shrestha A,Martin C,Burton M,et al.Quality of life versus length of life considerations in cancer patients: A systematic literature review[J].Psychooncology,2019,28(7):1367-1380.[6]Nipp RD,El-Jawahri A,Fishbein JN,et al.The Relationship Between Coping Strategies,Quality of Life, and Mood in Patients with Incurable Cancer[J].Cancer,2016,122(13):2110-2116.[7]刘恒旸.分级诊疗背景下不同等级医院护理核心竞争力协同提升路径研究[D].扬州:扬州大学,2017.[8]叶伟,段志兵,胡丽莉,等.不同等级医院血液透析患者原发病及死因的差异性分析[J].齐齐哈尔医学院学报,2016,26(7):99-101.[9]季沁,高银婷,周一帆,等.两所不同等级医院甲状腺结节诊疗现状的比较[J].江苏医药,2020,30(10):67-69.[10]姜悦,王晨,李子孝,等.不同等级医院缺血性脑血管病二级预防药物依从性研究[J].临床药物治疗杂志,2019,15(8):79-81.[11]Marcu MI,Knapp CA,Brown D,et al.Assessing The Impact of An Integrated Care System on The Healthcare Expenditures of Children with Special Healthcare Needs[J].American Journal of Managed Care,2016,22(4):272-280.[12]Zhang X,Oyama T.Investigating The Health Care Delivery System in Japan and Reviewing The Local Public Hospi tal Reform[J].Risk Management & Healthcare Policy,2016,9(1):21-32.[13]李华,徐英奇,高健.分级诊疗对家庭医疗经济负担的影响[J].江西财经大学学报,2018,19(5):49-52.[14]牛爱芳.西安市部分三甲医院住院癌症患者主要照顾者支持性需求与服务的研究[D].西安:第四军医大学,2016.[15]李臻.某三甲医院住院患者营养风险及营养支持情况调查分析[D].太原:山西医科大学,2017.[16]贺娅楠.庆阳市不同等级医院老年性白内障护理成本核算研究[D].兰州:甘肃中医药大学,2021.[17]龚伟,潘闽.南通地区不同等级医院急诊经皮冠状动脉介入治疗效果及安全性的比较[J].南通大学学报(医学版),2017,15(11):38-40.[18]Chen SC,Lai YH,Liao CT,et al.Unmet supportive care needs and characteristics of family caregivers of patients with oral cancer after surgery[J].Psychooncology,2014,23(5):569-577.[19]Meriggi F,Andreis F,Premi V,et al.Assessing cancer caregivers’ needs for an early targeted psychosocial support project: The experience of he oncology department of the Poliambulanza Foundation[J].Palliat Support Care,2017,13(4):865-873.[20]赵利群.甘肃省某三甲医院胃癌患者住院费用及影响因素分析[D].兰州:兰州大学,2019.

相似文献/References:

[1]胡平华,黄 勤,李志华.含卡培他滨方案一线或后线治疗晚期乳腺癌的效果对比[J].医学信息,2018,31(22):142.[doi:10.3969/j.issn.1006-1959.2018.22.041]
　HU Ping-hua,HUANG Qin,LI Zhi-hua.Comparison of the Efficacy of Capecitabine Regimen in the Treatment of Advanced Breast Cancer with First-line or Posterior Line Therapy[J].Journal of Medical Information,2018,31(02):142.[doi:10.3969/j.issn.1006-1959.2018.22.041]
[2]李 博.紫杉醇加顺铂治疗晚期老年非小细胞癌的疗效[J].医学信息,2020,33(10):153.[doi:10.3969/j.issn.1006-1959.2020.10.045]
　LI Bo.Paclitaxel Plus Cisplatin in the Treatment of Advanced Elderly Non-small Cell Carcinoma[J].Journal of Medical Information,2020,33(02):153.[doi:10.3969/j.issn.1006-1959.2020.10.045]
[3]徐勇平.舒肝宁注射液治疗晚期血吸虫病肝纤维化的效果及其对血清指标的影响[J].医学信息,2020,33(24):151.[doi:10.3969/j.issn.1006-1959.2020.24.043]
　XU Yong-ping.Shuganning Injection in the Treatment of Advanced Schistosomiasis Liver Fibrosis and Its Influence on Serum Indexes[J].Journal of Medical Information,2020,33(02):151.[doi:10.3969/j.issn.1006-1959.2020.24.043]

更新日期/Last Update: 1900-01-01